Table 1.xls (5.5 kB)
Baseline characteristics in the placebo / bee venom groups.
dataset
posted on 2016-07-12, 07:15 authored by Andreas Hartmann, Julia Müllner, Niklaus Meier, Helke Hesekamp, Priscilla van Meerbeeck, Marie-Odile Habert, Aurélie Kas, Marie-Laure Tanguy, Merry Mazmanian, Hervé Oya, Nissen Abuaf, Hafida Gaouar, Sabrina Salhi, Fanny Charbonnier-Beaupel, Marie-Hélène Fievet, Damien Galanaud, Sophie Arguillere, Emmanuel Roze, Bertrand Degos, David Grabli, Lucette Lacomblez, Cécile Hubsch, Marie Vidailhet, Anne-Marie Bonnet, Jean-Christophe Corvol, Michael SchüpbachBaseline characteristics in the placebo / bee venom groups.
History
Usage metrics
Categories
Keywords
11 month periodbee venom allergy desensitization protocolbee venomskin tests60 minute intervalbee venom injections40 Parkinson disease patientsdecrease UPDRS III scoresRandomized Controlled Clinical TrialYahr stages 1.5NCTbee venom administrationUPDRS III scoresplacebo 11 monthsParkinson disease patients
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC